Palomar Holdings reports strong earnings growth, premium valuations, and strategic expansion in crop and Surety insurance, highlighting its robust position in specialty insurance markets.

Agilon Health reports Q2 2025 results with $1.4B revenue, leadership changes, and suspends 2025 guidance amid Medicare Advantage market challenges and strategic operational shifts.

Lincoln National Corporation reported strong Q2 2025 results with a 28% EPS increase and a Risk-Based Capital ratio above 420%, driven by insurance premium growth and solid annuity and Group Protection performance.

Kansas City Life Insurance experiences significant decline in short interest and reports recent financial results with modest stock trading performance and dividend payout. Analysts maintain a Hold rating amid cautious market sentiment.

UnitedHealth's CEO Stephen Hemsley addresses investor concerns amid rising medical costs, regulatory investigations, and operational challenges affecting the insurer's 2025 earnings forecast and market confidence.

SBI Life Insurance reported strong Q1 results with 12% growth in value of new business and improved VNB margins, supported by stable bancassurance and positive market outlook from major analysts.

SBI Life Insurance's Q1 FY26 results reveal a strategic product mix shift driving VNB margin growth amid cost discipline and regulatory vigilance in India's insurance sector.

HCA Healthcare's Q2 2024 earnings demonstrate strategic growth fueled by digital transformation, aging demographics, and expansion into non-acute care. Strong financial metrics and operational discipline highlight market leadership.

Explore why Lincoln National, Lemonade, and AXIS Capital stocks require caution in portfolios amid market gains and risk exposures in the insurance sector.

Explore how Marsh & McLennan Companies leverages diversification and acquisitions to maintain growth and profitability amid softening insurance pricing and rising liability costs.